Ecron sets up office in Moscow
This article was originally published in Scrip
Ecron Acunova, a full-service clinical research organisation, has recently opened an office in Moscow, expanding its presence in Eastern Europe. Ecron, which has been active in Russia for several years via collaborations, believes that Russia has substantial unexplored capabilities. The market there offers high recruitment rates, low drop-out rates and high quality data, it said. Galyna Andriyko, who has been appointed as general manager, will lead the development of the Russian operations. Mrs Andriyko had previously set up operations in the Ukraine. The clinical team will be headed by Dr Vlad Linievych, a physician, with more than 13 years of experience in the industry.
You may also be interested in...
Pharmaceutical manufacturing in India is facing some early stress amid the new 21-day lock-down but both the industry and government machinery are actively engaged and working together to ensure that disruptions are minimized in the ‘pharmacy of the world.’
India has prohibited exports of hydroxychloroquine, though with concessions in specific instances, days after a national task force recommended the drug for the prophylaxis of SARS-CoV-2 infections. Home market supplies of the drug also appear strained for now.
Alembic says it is 'comfortably placed' in terms of inventories and is seeing improving API supplies from China. The only area of some concern is outbound logistics against a backdrop of flights being halted and population lock-downs.